Search the Newsreel

Fresenius Medical Care stock holds near $23 as investors weigh latest earnings

Fresenius Medical Care (FMS) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Opportunities in Healthcare with a 6.20% Upside Potential

Fresenius Medical Care AG & Co. KGaA $FMS Position Boosted by Sei Investments Co.

Sei Investments Co. significantly increased its stake in Fresenius Medical Care AG & Co. KGaA by 80.7%, now owning 120,704 shares. Other institutional investors like Morgan Stanley and Bank of America also boosted their positions, although overall institutional ownership remains at 8.37%. Despite beating …

Fresenius Medical Care AG 2026 Q2 - Results - Earnings Call Presentation (NYSE:FMS) 2026-08-07

Image source: The Motley Fool. DATE Tuesday, Aug. 4, 2026, at 9:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer and Chair of the Management Board - Helen Giza Chief Financial Officer - Martin Fischer Investor Relations - Dominik Heger Full Conference Call Transcript Operator: …

Barclays Sticks to Its Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Barclays has maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €44.50. This rating aligns with Goldman Sachs's Hold, while Jefferies reiterated a Sell rating on the company. Fresenius Medical Care currently has a market …

Fresenius Medical Care AG Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Fresenius Medical Care Launches 4008A™Dialysis Machine in China

Fresenius Medical Care has launched its 4008A™ dialysis machine in China, aiming to provide high-quality, cost-effective dialysis treatment to more patients suffering from end-stage renal disease (ESRD). The machine, a collaboration between their Chinese and German R&D teams, is designed to enhance accessibility and …

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Receives Average Rating of "Reduce" from Brokerages

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) has received an average rating of "Reduce" from eleven brokerage firms, with five recommending a sell and six a hold. The average 12-month price target is $22.45, below its opening price of $23.91. Despite the "Reduce" …

Jefferies Remains a Sell on Fresenius Medical Care AG & Co. KGaA (0H9X)

Jefferies analyst James Vane maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA (0H9X) with a price target of €31.00. This follows similar Sell ratings from UBS and a Hold rating from Bernstein on the same day. The article notes the …

Fresenius Medical Care (XTRA:FME) Expands BEACON US To Build Its Case For HVHDF

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care is expanding its BEACON-US clinical initiative to build real-world evidence for high-volume hemodiafiltration therapy in the U.S. The program evaluates …

FMS Q2 Earnings Rise on Care Delivery, Revenues Miss, Margins Expand

Fresenius Medical Care AG FMS reported second-quarter 2026 adjusted earnings per share (EPS) of 66 cents, which increased 28% year over year at constant currency (cc), supported by stronger Care Delivery profitability and share repurchases. FMS Posts Solid Organic Revenue Growth Revenues rose 0.9% …

Fresenius Medical Care (XTRA:FME) Stock Looks Like A Bargain Despite Weak Returns

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Fresenius Medical Care stock has recovered modestly in the short term yet is still down about 30% over the past five years, while recent valuation checks suggest …

Is Fresenius Medical Care (XTRA:FME) Undervalued Following Its New CEO Appointment?

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Fresenius Medical Care (XTRA:FME) has drawn fresh attention after the Supervisory Board appointed Cassie McLean as Management Board member and Chief Executive Officer …

Fresenius Medical Care targets ~20% 5008X conversion in 2026 while keeping operating income guidance at mid-single-digit % change

Earnings Call Insights: Fresenius Medical Care (FMS) Q2 2026 MANAGEMENT VIEW * "We continued our strong start to the year, delivering another quarter of highly profitable growth" (Chair of Management Board & CEO Helen Giza). She said operating income growth "accelerated to 23%" and …

Fresenius Medical Care AG (FMS) (Q2 2026) Earnings Call Highlights: Strong Profit Growth and ...

This article first appeared on GuruFocus. Revenue: Solid organic group revenue growth of 5% in Q2, with a 4% increase at constant currency. Operating Income: Increased significantly by 23% at constant currency, with growth accelerating and in line with planned phasing for 2026. Operating …

Fresenius Medical Care Shares Drop After U.S. Treatment Volumes Fall Further

Why is Fresenius Medical Care stock sliding today?

Fresenius Medical Care Shares Slide Despite Second-Quarter Earnings Beat

Researcher looking through microscope ©Adobe Stock Images Fresenius Medical Care (NYSE:FMS) shares fell 8.0% to €41.285 during Tuesday's trading session as investors looked beyond better-than-expected second-quarter results and focused instead on continued weakness in U.S. patient treatment volumes. Although the dialysis provider exceeded analyst …

Fresenius Medical Care's Margin Improvement Story Looks Merely Stalled, Not Over

Fresenius Medical Care GAAP EPS of EUR0.81, revenue of EUR4.86B

* Fresenius Medical Care press release [https://seekingalpha.com/pr/20604629-fresenius-medical-care-accelerates-income-growth-to-23-percent-in-the-second-quarter-of-2026] (FMS [https://seekingalpha.com/symbol/FMS]): Q2 GAAP EPS of EUR0.81. * Revenue of EUR4.86B. MORE ON FRESENIUS MEDICAL CARE * Fresenius Medical Care: More Favorable Patient Outcomes Will Drive Growth [https://seekingalpha.com/article/4923734-fresenius-medical-care-more-favorable-patient-outcomes-will-drive-growth] * Fresenius Medical: High Yield, Utilities-Like Stock At Valuation …

Fresenius Medical Care appoints McLean to management board By Investing.com

Fresenius Medical Care AG has appointed Cassie McLean to its Management Board as Chief Executive Officer of the Care Delivery operating segment, effective immediately. McLean, 48, previously served as President of Fresenius Kidney Care and will now oversee the global clinic business. She replaces …

Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery

BAD HOMBURG, Germany, Aug. 3, 2026 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care AG, the world's leading provider of products and services for individuals with renal disease, has appointed Cassie McLean (48) as a member of the Management Board, effective 1 August …

Fresenius Medical Care AG & Co. KGaA (FMS) Earnings Date and Reports 2026 $FMS

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Announces Earnings Results

Fresenius Medical Care's 5008X CAREsystem Tops 600,000 Treatments

Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda

Organic revenue growth1 of 5% with growth in all operating segments Operating income2 grew by 23%, resulting in further margin expansion to 11.7% Reported operating income grew by 10% and reported net income3 decreased by 3% Earnings per share2 (EPS) increased by 28%, supported …

Fresenius Medical Care AG (FMS) Stock Analysis: Navigating Challenges with Resilient Dividends and Modest Upside

Fresenius Medical Care (NYSE: FMS) lifts Q2 income and expands buybacks

Fresenius Medical Care (NYSE: FMS) lifts Q2 2026 profit 23% above views

Fresenius Medical Care stock trades steadily as dialysis margins and turnaround plan shape investor focus

Fresenius Medical Care stock continues to reflect the company's operational recovery in its global dialysis business, driven by steady patient volumes, improved operating performance, and margin recovery. The company reported a 5% revenue increase in Q1 2026, reaching EUR 5.00 billion, and its transformation …

BNP Paribas Exane Upgrades Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to "Strong Sell"

BNP Paribas Exane has downgraded Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) to a "strong sell" rating. This decision contributes to a cautious analyst sentiment, with the company currently holding an average "Reduce" rating and a consensus price target of $23.95. Despite some …

Fresenius Medical Care Number of Employees 2026 | Employee Count & Headcount Data

Fresenius Medical Care AG (FME) had approximately 110,828 total employees worldwide as of March 2026, marking a 3.6% decline since 2023. The company, headquartered in Germany, is actively hiring with 5,692 job postings in 2026, despite a significant year-over-year decline in new postings. Its …